Add a personal message:(80 character limit)
Your E-mail:
Sending your article
Your article has been sent.
When a tumor grows on an organ, doctors remove it. When a hip stops working, they replace it. When a faulty gene causes a disorder like Huntington’s disease or sickle cell anemia, however, there isn’t a surgery to fix the problem.
But a Cambridge company launching Monday aims to develop therapies that can put troublesome genes under the knife, so to speak, cutting out bad DNA like a scalpel excises bad tissue to treat diseases caused by genetic mutations.
“The way to think about it is molecular surgery,” said Dr. J. Keith Joung, director of the molecular pathology unit at Massachusetts General Hospital and a cofounder of the new company, Editas Medicine. “The idea is you can go in and make changes to the DNA.” Full story for BostonGlobe.com subscribers.
Callum Borchers can be reached at callum.borchers@globe.com . Follow him on Twitter @callumborchers .
© Copyright 2014 Globe Newspaper Company.
